Market Access Time to ask companies why they don’t submit to NICE? Companies can choose whether or not to submit to NICE to have their products appraised.
Views & Analysis VPAS: Achievements so far on affordability In the second part of this series taking stock of
Views & Analysis VPAS: Achievement so far on objectives for patients The UK has a voluntary agreement that was struck by the government and NHS England (now referred to as NHSE&I) with the Association of the British Pharmaceutical Industry (ABPI) in 2018
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
